ClinicalTrials.gov
public full text
Public Domain
A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea
The purpose of this study is to evaluate the safety by determining the incidence rates of all adverse events (AEs) including serious adverse events (SAEs)/serious adverse drug reactions (ADRs), unexpected AEs and ADRs that are not reflected on the precaution in the use, ADRs already known, non-serious ADRs and other safety related information (laboratory values changes, etc).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)#907784
- Electronic Pharmacotherapy Risk Management#840775
- A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea#891690
- Care Bundle for Prevention of Skin Complications and Edema in Restrained Patients#969299
- AZATHIOPRINUM 50 mg compr compr#350444
Record · ID 813701
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive